Parasin I

Parasin I is a cationic antimicrobial peptide originally isolated from the skin mucus of the Japanese flounder (Paralichthys olivaceus). As a member of the innate immune defense system in fish, it exhibits broad-spectrum activity against a range of Gram-negative and Gram-positive bacteria. Structurally, Parasin I is characterized by its amphipathic α-helical conformation, which facilitates interaction with microbial membranes. Its unique biochemical properties and mechanism of action have made it a valuable tool in peptide research, antimicrobial studies, and membrane biology, offering insights into host-pathogen interactions and the development of novel antimicrobial agents.

Antimicrobial mechanism studies: Parasin I serves as an important model for investigating the mechanisms underlying peptide-mediated microbial inhibition. Researchers utilize it to explore how cationic peptides disrupt bacterial cell membranes, leading to cell lysis or growth inhibition. By examining its interactions with lipid bilayers and characterizing its membrane-permeabilizing effects, scientists can better understand the structural requirements for antimicrobial activity and the factors influencing peptide selectivity and potency.

Peptide structure-activity relationship (SAR) research: The sequence and structural motifs of Parasin I make it an excellent candidate for SAR studies aimed at optimizing antimicrobial efficacy. Through systematic modification of amino acid residues or peptide length, researchers assess how changes impact biological activity, stability, and toxicity. These investigations inform the rational design of next-generation antimicrobial peptides with improved specificity and reduced cytotoxicity, contributing to the broader field of peptide therapeutics discovery.

Host-pathogen interaction modeling: Parasin I is frequently employed in experimental systems to model innate immune responses to microbial invasion. Its activity provides a platform for dissecting the molecular dialogues between host defense peptides and invading pathogens. By incorporating this peptide into in vitro or ex vivo assays, researchers can elucidate the regulatory pathways and signaling events that modulate immune responses, thereby advancing our understanding of innate immunity in aquatic and terrestrial organisms.

Antimicrobial peptide synthesis and functional assays: Synthetic production of Parasin I enables its use in a variety of functional assays, including bacterial growth inhibition, membrane permeabilization, and cytotoxicity testing. These applications are critical for validating peptide function, screening for synergistic effects with other antimicrobial agents, and benchmarking the activity of analogs. The availability of synthetic Parasin I supports robust experimental design in both academic and industrial research settings focused on peptide-based antimicrobial strategies.

Biophysical and membrane interaction studies: Owing to its well-characterized amphipathic structure, Parasin I is utilized in studies probing peptide-membrane interactions using techniques such as circular dichroism spectroscopy, fluorescence assays, and electron microscopy. These investigations yield quantitative and qualitative data on peptide binding, insertion, and disruption of model membranes, which are essential for elucidating the principles governing antimicrobial peptide function. The insights gained from such studies inform the broader design of membrane-active peptides and their potential applications in biotechnology and materials science.

1. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Implications of ligand-receptor binding kinetics on GLP-1R signalling

4. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes